Eli Lilly seeks FDA approval for weight loss drug tirzepatide – CBS News
Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.